Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase
- 1 January 1991
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 40 (S1) , S15-S18
- https://doi.org/10.1007/bf03216282
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.Proceedings of the National Academy of Sciences, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.Proceedings of the National Academy of Sciences, 1981